Nanomaterials appear in cosmetics as UV filters, colour pigments, preservatives & certain delivery forms, & they draw more regulatory attention than the same substances at a larger size. The reason is not a conclusion about safety but a question about identification: a material at the nano scale can behave differently, so the file has to describe it precisely enough to be assessed.
This article covers what a brand should ask its supplier, how the material is named on the label, & what the safety assessor needs to see. It does not settle whether any material is safe; that is the assessor's job on the evidence. Read it before you brief a product that may contain a nano-ingredient, because the documentation starts at the raw material, not at the pack.
What the term covers in cosmetics
A nanomaterial in this context is usually described by a size band: a material where a stated share of particles falls below a given dimension, measured in nanometres. The exact threshold & the counting rule are set by the market, & the brand should confirm the definition that applies where it sells rather than assume one that suited a different region.
Common cosmetic examples are mineral UV filters, some colourants & certain coated pigments. The point is not the substance name but the particle size distribution, because the same chemical at a larger size is not caught by the nano rules. A brand that knows only the INCI name does not yet know whether the nano rule applies, & it should not guess.
The size question is answered by the supplier, not by the brand. A factory buying a pigment or a filter should hold the particle-size data from the material maker, & the brand should ask for it early, because the answer decides whether the extra documentation is needed at all, & the need changes the launch timeline.
One subtlety is the coated particle. A nano-core with a coating is still assessed on the particle, & the coating does not remove it from the rule. The file should reflect the actual particle, not the coated description a supplier finds convenient to print, because the assessor works from the particle as supplied.
Why nanomaterials get special attention in the file
The attention comes from the way rules are written: where a cosmetic contains a nanomaterial, the file must identify it, the notification must name it, & the safety assessment must consider it specifically. The material is not barred by being named; it is simply required to be visible in the dossier rather than hidden inside a generic ingredient line that hides the scale.
For a brand the practical effect is that a nano-containing product needs more from its supplier than a standard one. The normal formula sheet is not enough; the particle data, the coating & the identity have to be documented so the assessor can work from them, & a brand that cannot show those items is not ready to launch into a market that asks for them.
The second effect is version control. A change in the particle source or the size distribution is a formula change for nano purposes even when the INCI name stays the same, because the material the assessor saw is no longer the material on sale. The file should regard a particle change as a new assessment trigger, not as a quiet reorder.
The reason this matters to a buyer is timing. A product that needs nano documentation takes longer to clear a market than an identical product without it, & the lead time should be built into the launch plan rather than discovered during the artwork review, when a delay costs a season rather than a week.
The notification duty where it applies
In some market systems a nanomaterial in a cosmetic must be listed in the notification, often in a dedicated field, & the responsible person must hold the supporting information. The duty is to name the material & to keep the evidence, not to obtain a pre-approval in every system, & the brand should confirm which markets require the separate field before it files.
The notification content usually includes the identity, the function, the size data & the toxicological position. A brand should ask the factory for these as a package, because assembling them from separate supplier letters after the fact is slower & more error-prone than asking at the brief stage, when the material is first chosen.
Where a market does not run a separate nano field, the material is still part of the composition & the safety assessment, so the documentation is needed even when the form looks the same. A brand should not read the absence of a special field as the absence of a duty, because the assessment still has to cover the particle whether or not a box exists for it.
The common miss is assuming the factory's notification covers the brand. The notification is usually the responsible person's, & if the brand is the responsible person it holds the duty itself. Confirming who notifies, & with what data, is the first question in any nano project, & it is the one most often left to chance.
Labelling: naming the material on the ingredient list
Where a market requires it, a nanomaterial is named in the ingredient list with a marker after the INCI name, so the shopper & the authority can see that the substance is present at the nano scale. The wording of the marker is set by the market, & the brand should use the exact form the rule specifies rather than a translation of its own that may not match.
The label duty is separate from the safety question. A correct nano label is not a warning or a judgement; it is an identification that lets the reader know the particle size. A brand should regard it as a labelling field like any other, & build it into the artwork with the rest of the list rather than as a special afterthought.
The difficulty is the shared INCI name. Two products can list the same ingredient yet only one is nano, so the label must carry the marker to separate them. The factory should confirm, per material, whether the version it uses triggers the marker, because the brand cannot tell from the name alone whether the rule applies to the batch it is buying.
For a multi-market pack the label rule differs, & the brand should decide whether to print the marker on every pack or to hold market-specific artwork. The file should hold each version, & the warehouse should know which label goes to which market, or the marker becomes a compliance gap that a single mixed carton can create.
The safety assessment questions assessors ask
The assessor's job is to conclude whether the product is safe under its intended use, & for a nano material that means specific questions: the identity, the particle size distribution, the coating, the solubility & the toxicological data. The brand does not answer these; it supplies the evidence the assessor needs, & the factory supplies the material data behind it.
The questions are not a verdict. An assessor who receives complete particle data & a sound toxicological set can assess the material; one who receives a name & a hope cannot, & the file simply stops at that point. The brand's role is to remove the gap, not to reach the conclusion, which is outside its remit.
A frequent gap is the toxicological position of the specific particle. Data on the bulk substance does not always cover the nano form, & the assessor may ask for particle-specific studies. A brand should know, before launch, whether such data exists for the material it is using, because a missing study is a launch blocker that no artwork tweak can fix.
The exposure question also matters: how the product is used, how much reaches the user, & whether the route changes for a leave-on versus a rinse-off. The assessment covers the use, so the brief should state the intended use clearly, or the assessor works from an assumption the brand did not intend & the file drifts from the product.
What the supplier must provide
For a nano material the supplier packet goes beyond a standard certificate. The brand should expect the material identity, the particle-size distribution with the method, the coating description, the purity & impurity profile, & the toxicological data where the market expects it. Each item should name the lot or the grade it covers, so the data can be tied to the warehouse.
The particle-size data is the one brands underestimate. A single number is not enough; the assessor wants the distribution, because the share below the threshold is what triggers the rule. A factory that supplies only an average has not supplied what the assessment needs, & the brand should ask for the full profile rather than accept a round figure.
The coating & the surface treatment matter because they change how the particle behaves, & the file should name them rather than describe the core alone. A coated nano-pigment is assessed on the particle as supplied, not on the bare material a data sheet happens to picture, & the two are not interchangeable for the assessor.
Where the material comes through a trader, the upstream data may be thinner, & the brand should know that before it commits to a market that expects particle-specific evidence. Asking early turns a possible blocker into a known constraint the brief can work around, & it protects the launch date from a late surprise.
The documentation gap buyers hit
The gap most brands meet is that the particle data exists at the material maker but does not travel to the brand. The factory may hold a certificate that names the grade without the distribution, or a distributor may forward a spec that restates the bulk rather than the nano form. The brand discovers this at assessment time, when it is too late to relabel cheaply.
A second gap is language. The data may exist in the maker's language but not in the one the market expects, & the brand should confirm the format at the brief stage. A certificate that cannot be read by the assessor is, for practical purposes, not held, & the duty is not met by a document no one can use in the market where it matters.
A third gap is version drift. The material maker updates a grade, the factory reorders without telling the brand, & the particle data in the file no longer matches the lot in the warehouse. The file should link the data to the lot, or the assessment quietly loses its subject & the brand is left defending a product it cannot fully describe.
The fix is to ask for the lot-linked data at ordering, to confirm the language, & to put the update duty in the quality agreement. Those three steps close most of the gaps a nano project meets, & they cost far less than a stopped launch that was otherwise ready to ship.
How a formula change reopens the question
A nano question is not a one-time box. Any change to the material source, the particle size, the coating or the concentration reopens it, because the assessor's subject has changed. A brand that regards the nano documentation as done at launch is wrong the moment the second batch uses a different lot, & the error shows up in a routine check.
The trap is the silent change. A factory switches to a second supplier of the same INCI name, the particle data differs, & the label marker stays. The product on sale no longer matches the file, & the brand learns it during a routine check rather than a planned review that would have caught it first.
The brief should state that a material change is a notification & assessment trigger, & the quality agreement should require the factory to tell the brand before the change rather than after. A supplier that notifies after the fact has not met the duty, & the brand carries the exposure for a product it can no longer fully document.
For a buyer the cheap control is a register of nano materials per product, with the approved source & lot data, reviewed at each reorder. The register turns an invisible dependency into a checked line, & it catches a silent switch before the pack is printed rather than after the goods have left the warehouse.
Market differences a brand must track
The nano rule is not uniform. The definition, the notification field, the label marker & the evidence expected differ by market, & a brand selling across several must track each. A product cleared in one market is not automatically cleared in another on the same particle, because the question is asked differently in each place it is sold.
Some markets maintain a list or a catalogue of the nanomaterials notified to them, & the brand should check whether its material appears & in what form. A material on a list is not approved by being listed; the listing is part of the transparency, & the assessment still stands behind it with the evidence the brand supplied.
The labelling difference is the one that breaks a single global pack. Where one market requires the marker & another does not, the brand holds market-specific artwork or prints the marker everywhere. The file should hold each version, & the team should know which label ships where so the right pack reaches the right market.
The practical advice is to confirm the rule per market at the brief stage & to review it at each launch, because a market can amend its definition or its expectation. A brand that checked two years ago may be working from a rule that has since moved, & the file should show the date it was confirmed so the age of the answer is visible.
How to brief a supplier on a nano-containing product
The brief should name the nano material explicitly, ask for the lot-linked particle data, state the markets & their label rules, & require notification of any change before it happens. A brief that regards the material as an ordinary ingredient misses the extra steps the particle requires, & the launch pays for it later in the form of a delay.
The brand should also ask who holds the assessment & the notification, because the duty follows the responsible person, not the factory. Naming that owner in the brief prevents the late discovery that no one booked the nano field, & it keeps the launch on its timeline rather than at the mercy of an unassigned task.
The supplier questions should be written, not assumed. A brand that assumes the factory supplies particle data because it supplies the pigment is wrong often enough to make the question explicit, & the explicit question is what the file later shows was asked, which is what an authority wants to see.
Finally, the brief should state the review rhythm: the nano register checked at each reorder, the data confirmed in the market's language, & the assessment revisited on any material change. That rhythm is what keeps a nano product compliant across its life rather than only on day one, when the first batch is freshest.
Supplier questions for a nano-containing product: what to ask, & why
The table below sets the questions a brand should put to its supplier against the reason each one is asked, what a complete answer contains & the risk if the question is left open. It is a checklist for the brief rather than a substitute for the assessment, which remains the assessor's work.
| Question for the supplier | Why it is asked | What a good answer contains | Risk if left open |
|---|---|---|---|
| Is the material nano under the market rule? | Decides whether extra docs apply | Particle-size distribution & the threshold used | Wrong labelling or missing notification |
| What is the particle-size distribution? | The share below the limit triggers the rule | Full distribution, not an average, with method | Assessor cannot work from a single number |
| What is the coating or surface treatment? | Changes how the particle behaves | Named coating with the grade it covers | Assessment on the wrong particle |
| What toxicological data exists? | The assessor needs particle-specific evidence | Study or statement covering the nano form | Launch blocked by a missing study |
| In what language is the data? | The market must be able to read it | Document in the accepted language | Certificate no one can use |
| Who notifies & holds the file? | The duty follows the responsible person | Named owner per market | Nano field never booked |
| What happens on a material change? | A switch reopens the question | Pre-change notice in the agreement | Silent switch, file out of date |
| Which markets require the label marker? | The pack rule differs by market | Market list & the exact marker form | Wrong or missing label on a market |
The rows are a starting checklist, not the whole duty, because the assessment itself is the assessor's work on the evidence supplied. The brand that asks these questions early holds the inputs the assessment needs, & the brand that does not is the one that stalls when the file is opened & the deadline is already close.
What to put in the brief
Brief a nano product with the particle in mind from the start. Name the material, the markets & the label rules, ask for the lot-linked data in the right language, & put the change-notice duty in the agreement so the file stays current after launch rather than only on the first batch, which is the easy one.
- The nano materials in the formula, & the markets each one ships to.
- The particle-size distribution, & the threshold each market uses.
- The coating or surface treatment, & the grade it covers.
- The toxicological data, & whether it covers the nano form.
- The language the documents must be in, & who verifies them.
- The responsible person, & who notifies the nano field.
- The change-notice duty, & the pre-change warning required.
- The label marker rule per market, & the artwork version held.
Then keep the nano register with the product file. A register checked at each reorder & on each material change keeps the documentation ahead of the batch, & the cost of that check is small against the cost of a product whose file no longer matches the pack on the shelf two markets away.
Where our capability fits
We document nano materials per product: the particle data, the coating & the lot link are recorded with the formula, & we confirm the market rule before the artwork is drawn. Where a material change would reopen the question, we flag it before the reorder rather than after, so the file stays matched to the batch the brand is actually shipping.
We work with brands on private label (your brand on a proven base), OEM/ODM contract manufacturing & full custom formula development, & the nano documentation is agreed at the brief stage. Our lines include retinol A alcohol essence capsules & a blue copper peptide repair serum, both produced with the same material-data discipline a nano question needs.
Tell us the markets you sell into & whether your formula may contain a nano material, & we will come back with the questions to put to the material maker & the documents to hold before launch. Start at our inquiry page, email capsulebiotech@163.com, or message the right team on WhatsApp: Capsule Series (capsules only) +86 158-7655-5319, Cosmetics Series (serum, hair care, body care, fragrance) +86 158-7655-5319. The ingredient identity rules are in our INCI & ingredient safety guide, & the document chain in our traceability article.
General manufacturing information, not regulatory or legal advice. Nanomaterial definitions, notification fields, label markers & evidence expected vary by market, & the applicable requirements should be confirmed for each destination before a product is placed on sale. This article does not assess the safety of any material; that is the assessor's task on the evidence.